"How will it help me?": Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder

Journal of Nervous and Mental Disease

Volumn 201, Issue 8, 2013, Pages 691-697

  Chen, Jessica A ^a   Keller, Stephanie M ^b   Zoellner, Lori A ^a   Feeny, Norah C ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Prolonged exposure; PTSD; Reasons; Sertraline; Treatment preference

Indexed keywords

SERTRALINE;

ADULT; ARTICLE; COGNITIVE THERAPY; DSM-IV; FEMALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; POSTTRAUMATIC STRESS DISORDER; PREDICTION; TREATMENT OUTCOME;

ADULT; CLIMACTERIC; FEMALE; HUMANS; IMPLOSIVE THERAPY; MALE; MIDDLE AGED; PATIENT PREFERENCE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS;

EID: 84881333005     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0b013e31829c50a9     Document Type: Article

References (48)

1. Addis ME, Carpenter KM (1999) Why, why, why?: Reason-giving and rumination as predictors of response to activation- and insight-oriented treatment rationales. J Clin Psychol. 55: 881-894. (Pubitemid 29318739)
2. Addis ME, Jacobson NS (1996) Reasons for depression and the process and outcome of cognitive-behavioral psychotherapies. J Consult Clin Psychol. 64: 1417-1424.
3. Angelo FN, Miller HE, Zoellner LA, Feeny NC (2008) ''I need to talk about it'': A qualitative analysis of trauma-exposed women's reasons for treatment choice. Behav Ther. 39: 13-21. (Pubitemid 351323795)
4. Bakker A, van Balkom AJ, Stein DJ (2005) Evidence-based pharmacotherapy of panic disorder. Int J Neuropsychopharmacol. 8: 473-482. (Pubitemid 41002501)
5. Barlow DH (2004) Psychological treatments. Am Psychol. 59: 869-878. (Pubitemid 40004752)
6. Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 67: 588-597. (Pubitemid 26382973)
7. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry. 4: 561-571.
8. Becker CB, Darius E, Schaumberg K (2007) An analog study of patient preferences for exposure versus alternative treatments for posttraumatic stress disorder. Behav Res Ther. 45: 2861-2873. (Pubitemid 350007433)
9. Becker CB, Meyer G, Price JS, Graham MM, Arsena A, Armstrong DA, Ramon E (2009) Law enforcement preferences for PTSD treatment and crisis management alternatives. Behav Res Ther. 47: 245-253.
10. Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K (2005) Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 29: 395-401. (Pubitemid 40446132)
11. Bystritsky A, Wagner AW, Russo JE, Stein MB, Sherbourne CD, Craske MG, Roy-Byrne PP (2005) Assessment of beliefs about psychotropic medication and psychotherapy: Development of a measure for patients with anxiety disorders. Gen Hosp Psychiatry. 27: 313-318. (Pubitemid 41317045)
12. Cahill SE, Foa EB (2004) A glass half empty or half full? Where we are and directions for future research in the treatment of PTSD. In Taylor S (Ed), Advances in the treatment of posttraumatic stress disorder: Cognitive-behavioral perspectives (pp 267-313). New York: Springer Publishing Co.
13. Choi YJ (2009) Efficacy of treatments for patients with obsessive-compulsive disorder: A systematic review. J Am Acad Nurse Pract. 21: 207-213.
14. Cochran BN, Pruitt L, Fukuda S, Zoellner LA, Feeny NC (2008) Reasons underlying treatment preference: An exploratory study. J Interpers Violence. 23: 276-291.
15. Davidson J, Rothbaum B, van der Kolk B, Sikes C, Farfel G (2001) Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 58: 485-492. (Pubitemid 32411330)
16. Dwight-Johnson M, Sherbourne C, Liao D, Wells K (2000) Treatment preferences among depressed primary care patients. J Gen Intern Med. 15: 527-534.
17. Dwight-Johnson M, Unutzer J, Sherbourne C, Tang L, Wells K (2001) Can quality improvement programs for depression in primary care address patient preferences for treatment? Med Care. 39: 934-944. (Pubitemid 33603651)
18. Eibner C, Ringel J, Kilmer B, Liccardo Pacula R, Diaz C (2008) The cost of postdeployment mental health and cognitive conditions. In Tanielian T, Jaycox LH (Eds), Invisible wounds of war: Psychological and cognitive injuries, their consequences, and services to assist recovery (pp 169-242). Washington, DC: RAND Corp Monograph Series.
19. First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, research version, patient edition with psychotic screen. New York: Biometrics Research, New York State Psychiatric Institute.
20. Feeny N, Zoellner L, Mavissakalian M, Roy-Byrne P (2009) What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women. Depress Anxiety. 26: 724-731.
21. Foa E, Tolin D (2000) Comparison of the PTSD Symptom ScaleYInterview Version and the Clinician-Administered PTSD Scale. J Trauma Stress. 13: 181-191. (Pubitemid 30333790)
22. Foa EB, Cashman L, Jaycox L, Perry K (1997) The validation of a self-report measure of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. 9: 445-451.
23. Foa EB, Keane TM, Friedman MJ, Cohen JA (2009) Effective treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (2nd ed). New York: Guilford Press.
24. Foa EB, Riggs DS, Dancu CV, Rothbaum BO (1993) Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress. 6: 459-473. (Pubitemid 24208473)
25. Fournier JC, DeRubeis RJ, Shelton RC, Hollon SD, Amsterdam JD, Gallop R (2009) Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol. 77: 775-787.
26. Frueh B, Cusack K, Grubaugh A, Sauvageot J, Wells C (2006) Clinicians' perspectives on cognitive-behavioral treatment for PTSD among persons with severe mental illness. Psychiatr Serv. 57: 1027-1031. (Pubitemid 44036235)
27. Givens J, Houston T, Van Voorhees B, Ford D, Cooper L (2007) Ethnicity and preferences for depression treatment. Gen Hosp Psychiatry. 29: 182-191. (Pubitemid 46680533)
28. Greenberg P, Sistsky T, Kessler R, Finkelstein S, Berndt E, Davidson J, Ballenger J, Fyer A, (1999) The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 60: 427-435. (Pubitemid 29369796)
29. Grilo C, Money R, Barlow D, Goddard A, Gorman J, Hofmann S, Papp L, Shear M, Woods S (1998) Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry. 39: 323-332. (Pubitemid 28523446)
30. Gross J, John O (2003) Individual differences in two emotion regulation processes: Implications for affect, relationships, and well-being. J Pers Soc Psychol. 85: 348-362. (Pubitemid 37394968)
31. Hazlett-Stevens H, Craske M, Roy-Byrne P, Sherbourne C, Stein M, Bystritsky A (2002) Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patients. Gen Hosp Psychiatry. 24: 316-321. (Pubitemid 36151667)
32. Hembree EA, Foa EB, Dorfan NM, Street GP, Kowalski J, Tu X (2003) Do patients drop out prematurely from exposure therapy for PTSD? J Trauma Stress. 16: 555-562. (Pubitemid 37541825)
33. Lobbestael J, Leurgans M, Arntz A (2011) Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clin Psychol Psychother. 18: 75-79.
34. Marmar CR, Weiss DS, Metzler TJ (1997) The Peritraumatic Dissociative Experiences Questionnaire. In: Wilson JP, Keane TM (Eds), Assessing psychological trauma and PTSD: a handbook for practitioners. New York, NY: Guilford Press.
35. Prins MA, Verhaak PFM, Bensing JM, van der Meer K (2008) Health beliefs and perceived need for mental health care of anxiety and depressionVThe patients' perspective explored. Clin Psychol Rev. 28: 1038-1058.
36. Reger GM, Durham TL, Tarantino KA, Luxton DD, Holloway KM, Lee JA (2012) Deployed soldiers' reactions to exposure and medication treatments for PTSD. Psychol Trauma. doi: 10.1037/a0028409.
37. Reiss S, Peterson R, Gursky D, McNally R (1986) Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther. 24: 1-8. (Pubitemid 16207745)
38. Roy-Byrne P, Berliner L, Russo J, Zatzick D, Pitman R (2003) Treatment preferences and determinants in victims of sexual and physical assault. J Nerv Ment Dis. 191: 161-165. (Pubitemid 36323956)
39. Simon V, Feiring C, McElroy S (2010) Making meaning of traumatic events: Youths' strategies for processing childhood sexual abuse are associated with psychosocial adjustment. Child Maltreat. 15: 229-241.
40. Spoont M, Sayer N, Nelson D (2005) PTSD and treatment adherence: The role of health beliefs. J Nerv Ment Dis. 193: 515-522. (Pubitemid 41140938)
41. Sullivan G, Neria Y (2009) Pharmacotherapy in post-traumatic stress disorder: Evidence from randomized controlled trials. Curr Opin Investig Drugs. 10: 35-45.
42. Tanielian T, Jaycox LH (2008) Invisible wounds of war: Psychological and cognitive injuries, their consequences, and services to assist recovery. Washington, DC: RAND Corp Monograph Series.
43. van Minnen A, Hendriks L, Olff M (2010) When do trauma experts choose exposure therapy for PTSD patients? A controlled study of therapist and patient factors. Behav Res Ther. 48: 312-320.
44. Wagner A, Bystritsky A, Russo J, Craske M, Sherbourne C, Stein M, Roy-Byrne P (2005) Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders. Depress Anxiety. 21: 99-105. (Pubitemid 41040631)
45. Wang P, Berglund P, Olfson M, Pincus H, Wells K, Kessler R (2005) Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62: 603-613. (Pubitemid 40973435)
46. Zayfert C, Black C (2000) Implementation of empirically supported treatment for PTSD: Obstacles and innovations. Behav Therapist. 23: 161-168.
47. Zoellner L, Feeny N, Bittinger J (2009) What you believe is what you want: Modeling PTSD-related treatment preferences for sertraline or prolonged exposure. J Behav Ther Exp Psychiatry. 40: 455-467.
48. Zoellner L, Feeny N, Cochran B, Pruitt L (2003) Treatment choice for PTSD. Behav Res Ther. 41: 879-886. (Pubitemid 36918176)